Early safety study of new drug GSM-779690T cancelled before starting
Knowledge-focused
Terminated
This study was designed to test the safety of an experimental drug called GSM-779690T in healthy adults. It was a first-in-human trial with two parts: single and multiple doses. The study was withdrawn before any participants were enrolled, so no results are available.
Phase: PHASE1 • Sponsor: Acta Pharmaceuticals, Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC